Moreover, the inhibition of TRPM8 has been observed to decrease the number of F4/80-positive cells and suppress the activation of HSCs and cholangiocytes by reducing gene expression levels of IL-6, IL-1β, TNFα, and MCP-1 in a mouse liver fibrosis model. The gene discussed is TRPM8; the disease is Hepatic fibrosis.